ter 286 has been researched along with nov 002 in 1 studies
Studies (ter 286) | Trials (ter 286) | Recent Studies (post-2010) (ter 286) | Studies (nov 002) | Trials (nov 002) | Recent Studies (post-2010) (nov 002) |
---|---|---|---|---|---|
21 | 7 | 1 | 62 | 6 | 27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Findlay, VL; Tew, KD; Townsend, DM | 1 |
1 review(s) available for ter 286 and nov 002
Article | Year |
---|---|
Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets.
Topics: 4-Aminobenzoic Acid; Animals; Antineoplastic Agents; Azo Compounds; Cisplatin; Cytotoxins; Drug Combinations; Glutathione; Glutathione Disulfide; Glutathione Transferase; Humans; Molecular Structure; Neoplasms; Oxidative Stress; para-Aminobenzoates; Prodrugs; Protein Kinases; Signal Transduction | 2005 |